speb/financial-data huggingface dataset:
Financial ratios for BLX.TO — annual report dated 2024-12-31
Total revenue: 596503496.5034965
Operating income: 161538461.53846154
Net income: 51748251.74825175
Capital expenditures: 278321678.32167834
Operating cash flow: 150349650.34965035
Depreciation & amortization: 207692307.6923077
Net tangible assets: 280419580.41958046
Owner earnings: -18881118.881118894
Return on net tangible assets (%): -6.733167082294268
Capex to operating income (%): 172.2943722943723
Buffett classification: The Gruesome
Stock price: 19.412587412587413
P/E ratio: 38.54714623459459
Shares outstanding: 102755361
Book value: 1416083916.0839157
P/B ratio: 1.4086364549925932
Market cap (USD): 1994747427.5244756
Debt to equity: 2.1239506172839513
Current ratio: 0.9564766839378239
Quick ratio: 0.9564766839378239
Effective tax rate (%): 32.72727272727273
Interest coverage ratio: 1.8934426229508197
COGS to revenue (%): 0
R&D to revenue (%): 6.682297772567409
SG&A to revenue (%): 8.792497069167645
Free cash flow (dilution-adjusted): -165734265.73426574
Buyback yield (%): 0
Retained earnings: 105594405.5944056
Receivables turnover: 3.231060606060606
Capitalized R&D asset: 70708401.89222543
ROCI (R&D-adjusted, %): 3.5783350071903253
FCF margin (%): -27.784290738569755
Revenue growth (%): -22.956495559235282
Rule of 40 score: -50.74078629780504
Financial ratios for BLX.TO — quarterly report dated 2025-03-31
Total revenue: 165734265.73426574
Operating income: 49650349.650349654
Net income: 28671328.67132867
Capital expenditures: 194405594.4055944
Operating cash flow: 120279720.27972029
Depreciation & amortization: 51748251.74825175
Net tangible assets: 277622377.62237763
Owner earnings: -113986013.98601398
Return on net tangible assets (%): -41.05793450881612
Capex to operating income (%): 391.5492957746479
Buffett classification: The Gruesome
Stock price: 19.664335664335667
P/E ratio: 17.618785069024394
Shares outstanding: 102755361
Book value: 1431468531.4685316
P/B ratio: 1.4115685155446995
Market cap (USD): 2020615910.0139863
Debt to equity: 2.1406936980947724
Current ratio: 0.938364779874214
Quick ratio: 0.938364779874214
Effective tax rate (%): 26.785714285714285
Interest coverage ratio: 2.0285714285714285
COGS to revenue (%): 0
R&D to revenue (%): 4.641350210970464
SG&A to revenue (%): 7.59493670886076
Free cash flow (dilution-adjusted): -76923076.92307693
Buyback yield (%): 0
Retained earnings: 114685314.68531469
Receivables turnover: 0.99163179916318
Capitalized R&D asset: 7692307.692307693
ROCI (R&D-adjusted, %): 1.1522996959890164
FCF margin (%): -46.41350210970464
Rule of 40 score: -46.41350210970464
Financial ratios for BLX.TO — quarterly report dated 2025-06-30
Total revenue: 143795620.43795618
Operating income: 25547445.255474452
Net income: -2919708.02919708
Capital expenditures: 102919708.02919707
Operating cash flow: 78102189.7810219
Depreciation & amortization: 57664233.576642334
Net tangible assets: 270802919.70802915
Owner earnings: -48175182.481751814
Return on net tangible assets (%): -17.78975741239892
Capex to operating income (%): 402.85714285714283
Buffett classification: The Gruesome
Stock price: 22.56934306569343
P/E ratio: 90.05728324740537
Shares outstanding: 102755361
Book value: 1462773722.627737
P/B ratio: 1.5854270270059883
Market cap (USD): 2319120994.248175
Debt to equity: 2.263473053892216
Current ratio: 1.0799373040752351
Quick ratio: 1.0799373040752351
Interest coverage ratio: 0.8974358974358975
COGS to revenue (%): 0
R&D to revenue (%): 7.614213197969544
SG&A to revenue (%): 10.659898477157363
Free cash flow (dilution-adjusted): -37226277.37226277
Buyback yield (%): 0.06294859208377798
Retained earnings: 99270072.99270073
Receivables turnover: 0.8454935622317596
Capitalized R&D asset: 16102751.263335206
ROCI (R&D-adjusted, %): 0.5971044420178926
FCF margin (%): -25.888324873096447
Revenue growth (%): -13.23724167667623
Rule of 40 score: -39.12556654977268
Financial ratios for BLX.TO — quarterly report dated 2025-09-30
Total revenue: 112949640.2877698
Operating income: -719424.4604316547
Net income: -19424460.431654677
Capital expenditures: 55395683.453237414
Operating cash flow: 26618705.035971224
Depreciation & amortization: 58992805.75539569
Net tangible assets: 229496402.87769786
Owner earnings: -15827338.129496403
Return on net tangible assets (%): -6.896551724137931
Buffett classification: The Gruesome
Stock price: 19.215827338129497
P/E ratio: 312.0719579336105
Shares outstanding: 102755361
Book value: 1407913669.0647483
P/B ratio: 1.4024505326060297
Market cap (USD): 1974529275.0431654
Debt to equity: 2.3679100664282062
Current ratio: 1.260147601476015
Quick ratio: 1.260147601476015
Interest coverage ratio: -0.023809523809523808
COGS to revenue (%): 0
R&D to revenue (%): 10.19108280254777
SG&A to revenue (%): 10.19108280254777
Free cash flow (dilution-adjusted): -34532374.10071943
Buyback yield (%): 0
Retained earnings: 66906474.820143886
Receivables turnover: 0.5432525951557093
Capitalized R&D asset: 21385019.328725677
ROCI (R&D-adjusted, %): 0.014442573900522743
FCF margin (%): -30.573248407643316
Revenue growth (%): -21.451265383632162
Rule of 40 score: -52.02451379127548
Financial ratios for BLX.TO — annual report dated 2025-12-31
Total revenue: 619708029.1970803
Operating income: 133576642.33576642
Net income: 24087591.24087591
Capital expenditures: 445985401.459854
Operating cash flow: 264233576.64233574
Depreciation & amortization: 234306569.34306568
Net tangible assets: 251824817.51824814
Owner earnings: -187591240.87591243
Return on net tangible assets (%): -74.49275362318842
Capex to operating income (%): 333.879781420765
Buffett classification: The Gruesome
Stock price: 18.299270072992698
P/E ratio: 78.06293637181818
Shares outstanding: 102755361
Book value: 1453284671.5328465
P/B ratio: 1.2938608238422904
Market cap (USD): 1880348102.386861
Debt to equity: 2.340030135610246
Current ratio: 1.2862745098039217
Quick ratio: 1.2862745098039217
Effective tax rate (%): 10.81081081081081
Interest coverage ratio: 1.1883116883116884
COGS to revenue (%): 0
R&D to revenue (%): 7.302709069493521
SG&A to revenue (%): 8.362779740871613
Free cash flow (dilution-adjusted): -213138686.13138685
Buyback yield (%): 0
Retained earnings: 65693430.6569343
Receivables turnover: 3.0760869565217392
Capitalized R&D asset: 83211768.15884845
ROCI (R&D-adjusted, %): 2.627721333378536
FCF margin (%): -34.39340400471143
Revenue growth (%): 3.890091647341703
Rule of 40 score: -30.503312357369726
Financial ratios for BLX.TO — quarterly report dated 2025-12-31
Total revenue: 188321167.88321167
Operating income: 56934306.56934306
Net income: 18978102.18978102
Capital expenditures: 83941605.83941606
Operating cash flow: 33576642.33576642
Depreciation & amortization: 62773722.627737224
Net tangible assets: 251824817.51824814
Owner earnings: -2189781.0218978077
Return on net tangible assets (%): -0.8695652173913035
Capex to operating income (%): 147.43589743589746
Buffett classification: The Gruesome
Stock price: 18.299270072992698
P/E ratio: 74.30660360857175
Shares outstanding: 102755361
Book value: 1453284671.5328465
P/B ratio: 1.2938608238422904
Market cap (USD): 1880348102.386861
Debt to equity: 2.340030135610246
Current ratio: 1.2862745098039217
Quick ratio: 1.2862745098039217
Effective tax rate (%): 7.142857142857142
Interest coverage ratio: 2.0526315789473686
COGS to revenue (%): 0
R&D to revenue (%): 7.751937984496124
SG&A to revenue (%): 6.2015503875969
Free cash flow (dilution-adjusted): -60583941.60583941
Buyback yield (%): 0
Retained earnings: 65693430.6569343
Receivables turnover: 0.9347826086956522
Capitalized R&D asset: 25923909.04794413
ROCI (R&D-adjusted, %): 1.130223190046379
FCF margin (%): -32.17054263565891
Revenue growth (%): 66.73020596029568
Rule of 40 score: 34.559663324636766
Financial ratios for BNTX — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 8295454.545454546
Buffett classification: The Gruesome
Stock price: 254.43
Shares outstanding: 252884261
Market cap (USD): 64341342526.23
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNTX — annual report dated 2022-12-31
Total revenue: 18415531914.89362
Gross profit: 15229361702.12766
Operating income: 13089148936.170214
Net income: 10036595744.680851
Capital expenditures: 349574468.08510643
Operating cash flow: 14444042553.19149
Depreciation & amortization: 131170212.76595746
Net tangible assets: 21102021276.595745
Owner earnings: 9818191489.361702
Return on net tangible assets (%): 46.52725613660081
Capex to operating income (%): 2.670719615078269
Buffett classification: The Great
Stock price: 150.22
P/E ratio: 3.7849759673296446
Shares outstanding: 252884261
Book value: 21335744680.851063
P/B ratio: 1.7804990758777997
Market cap (USD): 37988273687.42
Debt to equity: 0.01058058597100062
Current ratio: 7.429675320273843
Quick ratio: 7.280688673490137
Effective tax rate (%): 27.170548320608916
Interest coverage ratio: 650.994708994709
COGS to revenue (%): 17.30153778609638
R&D to revenue (%): 8.87895278037734
SG&A to revenue (%): 3.126408096773075
Free cash flow (dilution-adjusted): 13942021276.595745
Buyback yield (%): 2.7623305832798635
Retained earnings: 20035106382.978725
Inventory turnover: 6.813011828935396
Receivables turnover: 2.422418136020151
Capitalized R&D asset: 1635106382.9787235
ROCI (R&D-adjusted, %): 60.956605916474196
FCF margin (%): 75.70794773144777
Rule of 40 score: 75.70794773144777
Financial ratios for BNTX — annual report dated 2023-12-31
Total revenue: 4243333333.333333
Gross profit: 3576888888.888889
Operating income: 972888888.8888888
Net income: 1033666666.6666666
Capital expenditures: 277888888.8888889
Operating cash flow: 5968222222.222222
Depreciation & amortization: 203777777.77777776
Net tangible assets: 21199222222.22222
Owner earnings: 959555555.5555556
Return on net tangible assets (%): 4.526371512581698
Capex to operating income (%): 28.56327089995432
Buffett classification: The Good
Stock price: 105.54
P/E ratio: 25.820127287268626
Shares outstanding: 252884261
Book value: 22495444444.444443
P/B ratio: 1.1864359902669679
Market cap (USD): 26689404905.940002
Debt to equity: 0.010821944196108843
Current ratio: 9.431200193190051
Quick ratio: 9.258439990340499
Effective tax rate (%): 21.56647837450468
Interest coverage ratio: 116.74666666666667
COGS to revenue (%): 15.705682115737105
R&D to revenue (%): 46.69023304529982
SG&A to revenue (%): 15.373134328358212
Free cash flow (dilution-adjusted): 5127222222.222222
Buyback yield (%): 3.0744617890409853
Retained earnings: 21959222222.22222
Inventory turnover: 1.676824154319262
Receivables turnover: 1.6322605462238748
Capitalized R&D asset: 3076743498.817967
ROCI (R&D-adjusted, %): 6.639148305572255
Rosenberg metric: -7.126430998337309
FCF margin (%): 120.83006022518985
Revenue growth (%): -76.95785626533262
Rule of 40 score: 43.87220395985723
Financial ratios for BNTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 118.77
Shares outstanding: 252884261
Market cap (USD): 30035063678.969997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 113.95
Shares outstanding: 252884261
Market cap (USD): 28816161540.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNTX — annual report dated 2024-12-31
Total revenue: 2865729166.666667
Gross profit: 2301875000
Operating income: -738958333.3333334
Net income: -693020833.3333334
Capital expenditures: 297187500
Operating cash flow: 216354166.6666667
Depreciation & amortization: 310416666.6666667
Net tangible assets: 19000104166.666668
Owner earnings: -679791666.6666667
Return on net tangible assets (%): -3.5778312618900117
Buffett classification: The Gruesome
Stock price: 113.95
Shares outstanding: 252884261
Book value: 20219895833.333332
P/B ratio: 1.4251389709656848
Market cap (USD): 28816161540.95
Debt to equity: 0.01309559994024038
Current ratio: 7.452243183259354
Quick ratio: 7.3399651236525045
Interest coverage ratio: -41.976331360946745
COGS to revenue (%): 19.67576605721348
R&D to revenue (%): 81.93813383737412
SG&A to revenue (%): 25.906001235869287
Free cash flow (dilution-adjusted): -359895833.3333334
Buyback yield (%): 0
Retained earnings: 19893750000
Inventory turnover: 1.9106953759265797
Receivables turnover: 1.8053021851827549
Capitalized R&D asset: 4215128995.2718678
ROCI (R&D-adjusted, %): -1.5125963211657447
Rosenberg metric: -0.6435491559643318
FCF margin (%): -12.558612918468976
Revenue growth (%): -32.46514139827178
Rule of 40 score: -45.02375431674076
Financial ratios for BNTX — quarterly report dated 2025-03-31
Total revenue: 198695652.17391303
Gross profit: 107608695.6521739
Operating income: -610326086.9565217
Net income: -451956521.73913044
Capital expenditures: 52608695.652173914
Operating cash flow: -848586956.5217391
Depreciation & amortization: 46521739.13043478
Net tangible assets: 18521195652.173912
Owner earnings: -458043478.26086956
Return on net tangible assets (%): -2.473077261656739
Buffett classification: The Gruesome
Stock price: 91.06
Shares outstanding: 252884261
Book value: 20572391304.347824
P/B ratio: 1.1193468209888306
Market cap (USD): 23027640806.66
Debt to equity: 0.015480857628945506
Current ratio: 10.182795698924732
Quick ratio: 10.01700879765396
Interest coverage ratio: -151.75675675675677
COGS to revenue (%): 45.842450765864335
R&D to revenue (%): 287.527352297593
SG&A to revenue (%): 80.1422319474836
Free cash flow (dilution-adjusted): -1544456521.7391303
Buyback yield (%): 0
Retained earnings: 20306739130.43478
Inventory turnover: 0.32940251572327045
Receivables turnover: 0.17799415774099317
Capitalized R&D asset: 571304347.8260869
ROCI (R&D-adjusted, %): -1.046422286663197
FCF margin (%): -777.2975929978118
Rule of 40 score: -777.2975929978118
Financial ratios for BNTX — quarterly report dated 2025-06-30
Total revenue: 306823529.41176474
Gross profit: 216941176.47058824
Operating income: -562941176.4705882
Net income: -454823529.41176474
Capital expenditures: 31294117.647058826
Operating cash flow: 172352941.1764706
Depreciation & amortization: 60000000
Net tangible assets: 19592941176.47059
Owner earnings: -426117647.0588236
Return on net tangible assets (%): -2.174852888195028
Buffett classification: The Gruesome
Stock price: 106.47
Shares outstanding: 252884261
Book value: 21770705882.35294
P/B ratio: 1.2367346935909291
Market cap (USD): 26924587268.67
Debt to equity: 0.014568956666000187
Current ratio: 8.60660255024854
Quick ratio: 8.481953749729845
Interest coverage ratio: -140.73529411764704
COGS to revenue (%): 29.29447852760736
R&D to revenue (%): 195.2070552147239
SG&A to revenue (%): 52.6840490797546
Free cash flow (dilution-adjusted): 99058823.52941176
Buyback yield (%): 0
Retained earnings: 21524235294.11765
Inventory turnover: 0.33116601647160815
Receivables turnover: 0.18027234395520841
Capitalized R&D asset: 981715089.5140665
ROCI (R&D-adjusted, %): -1.4595111886756456
Rosenberg metric: 0.19137344435491097
FCF margin (%): 32.28527607361963
Revenue growth (%): 54.41884412408292
Rule of 40 score: 86.70412019770255
Financial ratios for BNTX — quarterly report dated 2025-09-30
Total revenue: 283641456.5882353
Gross profit: 109170868.35294117
Operating income: -734005602.2352941
Net income: -33764705.88235294
Capital expenditures: 38823529.4117647
Operating cash flow: 918470588.2352941
Depreciation & amortization: 146117647.05882353
Net tangible assets: 19682117647.058823
Owner earnings: 73529411.76470587
Buffett classification: The Gruesome
Stock price: 98.62
Shares outstanding: 252884261
Book value: 21738000000.000004
P/B ratio: 1.14727416596835
Market cap (USD): 24939445819.82
Debt to equity: 0.01328116120861814
Current ratio: 7.1229246344206985
Quick ratio: 7.021372328458943
Effective tax rate (%): 216.19433198380568
COGS to revenue (%): 61.51096187909321
R&D to revenue (%): 234.26427019090923
SG&A to revenue (%): 61.593916648990835
Free cash flow (dilution-adjusted): 840235294.117647
Buyback yield (%): 0
Retained earnings: 21490470588.235294
Inventory turnover: 0.6570669029685423
Receivables turnover: 0.3073234392606756
Capitalized R&D asset: 1254291611.253197
ROCI (R&D-adjusted, %): -2.8682101828826476
Rosenberg metric: -0.17993471204085643
FCF margin (%): 296.2314833044394
Revenue growth (%): -7.555506863496935
Rule of 40 score: 288.67597644094246
Financial ratios for BNTX — annual report dated 2025-12-31
Total revenue: 3376352941.1764708
Gross profit: 2621294117.647059
Operating income: -753764705.882353
Net income: -1336588235.2941177
Capital expenditures: 200705882.3529412
Operating cash flow: 536470588.2352941
Depreciation & amortization: 450352941.1764706
Net tangible assets: 20294470588.235294
Owner earnings: -1086941176.4705884
Return on net tangible assets (%): -5.355848883787529
Buffett classification: The Gruesome
Stock price: 95.2
Shares outstanding: 252884261
Book value: 22616705882.352943
P/B ratio: 1.0644601283860966
Market cap (USD): 24074581647.2
Debt to equity: 0.013909551502793351
Current ratio: 7.5370396303038785
Quick ratio: 7.485366195210755
Interest coverage ratio: -45.11971830985915
COGS to revenue (%): 22.363148541761035
R&D to revenue (%): 73.3440189553643
SG&A to revenue (%): 24.32837381093418
Free cash flow (dilution-adjusted): -469647058.8235295
Buyback yield (%): 0
Retained earnings: 21131647058.82353
Inventory turnover: 5.797651309846431
Receivables turnover: 2.913899888313534
Capitalized R&D asset: 4703400024.509804
ROCI (R&D-adjusted, %): -1.946309405173679
Rosenberg metric: 0.13603156460880872
FCF margin (%): -13.909892330743231
Revenue growth (%): 17.818284450925507
Rule of 40 score: 3.9083921201822758
Financial ratios for BNTX — quarterly report dated 2025-12-31
Total revenue: 1314470588.235294
Gross profit: 675411764.7058824
Operating income: -330000000
Net income: -358823529.41176474
Capital expenditures: 73058823.52941176
Operating cash flow: 364117647.0588235
Depreciation & amortization: 193882352.94117647
Net tangible assets: 20294470588.235294
Owner earnings: -238000000.00000003
Return on net tangible assets (%): -1.1727332278279219
Buffett classification: The Gruesome
Stock price: 95.2
Shares outstanding: 252884261
Book value: 22616705882.352943
P/B ratio: 1.0644601283860966
Market cap (USD): 24074581647.2
Debt to equity: 0.013909551502793351
Current ratio: 7.5370396303038785
Quick ratio: 7.485366195210755
COGS to revenue (%): 29.830842208896446
R&D to revenue (%): 45.234046361764975
SG&A to revenue (%): 26.107580775082788
Free cash flow (dilution-adjusted): 262705882.35294122
Buyback yield (%): 0
Retained earnings: 21131647058.82353
Inventory turnover: 3.0108401084010836
Receivables turnover: 1.1344298913595288
Capitalized R&D asset: 1237434117.647059
ROCI (R&D-adjusted, %): -1.4428730802678142
Rosenberg metric: 0.8521684877832862
FCF margin (%): 19.985679763716107
Revenue growth (%): 363.42682203311415
Rule of 40 score: 383.41250179683027
Financial ratios for BOL.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9548872180451128
Shares outstanding: 36968491
Market cap (USD): 35300739.526315786
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOL.AX — annual report dated 2022-06-30
Total revenue: 148857931.03448278
Gross profit: 148857931.03448278
Operating income: 4727586.206896552
Net income: 2614482.7586206896
Capital expenditures: 1549655.1724137932
Depreciation & amortization: 23774482.75862069
Net tangible assets: 76019310.34482759
Owner earnings: 24839310.34482759
Return on net tangible assets (%): 32.67500090721051
Capex to operating income (%): 32.77899343544858
Buffett classification: The Good
Stock price: 1.0206896551724138
P/E ratio: 14.43243647586389
Shares outstanding: 36968491
Book value: 76019310.34482759
P/B ratio: 0.49636541241789744
Market cap (USD): 37733356.33103448
Debt to equity: 0.4300812860616177
Current ratio: 0.7557149766242142
Quick ratio: 0.7074480090278897
Effective tax rate (%): 0
Interest coverage ratio: 3.566597294484912
COGS to revenue (%): 0
SG&A to revenue (%): 46.68278942198996
Free cash flow (dilution-adjusted): 20865517.24137931
Buyback yield (%): 0
Retained earnings: -140161379.31034485
Inventory turnover: 0
Receivables turnover: 5.613628088426529
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.324106435528217
FCF margin (%): 14.01706788235948
Rule of 40 score: 14.01706788235948
Financial ratios for BOL.AX — annual report dated 2023-06-30
Total revenue: 136339072.84768212
Gross profit: 136339072.84768212
Operating income: 3675496.6887417217
Net income: -3417880.794701987
Capital expenditures: 486754.9668874172
Depreciation & amortization: 22309271.52317881
Net tangible assets: 69889403.97350994
Owner earnings: 18404635.761589404
Capex to operating income (%): 13.243243243243244
Buffett classification: The Great
Stock price: 0.7483443708609271
Shares outstanding: 36968491
Book value: 69889403.97350995
P/B ratio: 0.39584200989264007
Market cap (USD): 27665162.139072847
Debt to equity: 0.6027782778846426
Current ratio: 0.8055067519909717
Quick ratio: 0.7541839260294703
Interest coverage ratio: 3.0048727666486195
COGS to revenue (%): 0
SG&A to revenue (%): 52.711879225926786
Free cash flow (dilution-adjusted): 16011258.278145695
Buyback yield (%): 0
Retained earnings: -138009933.77483442
Inventory turnover: 0
Receivables turnover: 4.89693394543422
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.292077829677978
FCF margin (%): 11.743704826299837
Revenue growth (%): -8.40993697803087
Rule of 40 score: 3.333767848268966
Financial ratios for BOL.AX — annual report dated 2024-06-30
Total revenue: 172820666.66666666
Gross profit: 172820666.66666666
Operating income: 8150000
Net income: 4406000
Capital expenditures: 1776000
Depreciation & amortization: 22366666.666666668
Net tangible assets: 74016000
Owner earnings: 24996666.666666668
Return on net tangible assets (%): 33.77197723014844
Capex to operating income (%): 21.791411042944787
Buffett classification: The Great
Stock price: 0.9866666666666667
P/E ratio: 8.27861502193978
Shares outstanding: 36968491
Book value: 74016000.00000001
P/B ratio: 0.4928066605418647
Market cap (USD): 36475577.78666667
Debt to equity: 0.735597708603545
Current ratio: 0.9657762325983951
Quick ratio: 0.9187020493186051
Effective tax rate (%): 0
Interest coverage ratio: 4.732868757259001
COGS to revenue (%): 0
SG&A to revenue (%): 50.01716615682539
Free cash flow (dilution-adjusted): 14128666.666666666
Buyback yield (%): 2.229802466982827
Retained earnings: -134524000
Inventory turnover: 0
Receivables turnover: 6.008924225214992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.009225229770716
FCF margin (%): 8.175333968545429
Revenue growth (%): 26.75798878267402
Rule of 40 score: 34.93332275121945
Financial ratios for CLST — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.67
Shares outstanding: 4051896
Market cap (USD): 55389418.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLST — annual report dated 2022-12-31
Total revenue: 8336000
Net income: 180000
Capital expenditures: 252000
Operating cash flow: 772000
Depreciation & amortization: 448000
Net tangible assets: 88512000
Owner earnings: 376000
Return on net tangible assets (%): 0.42480115690527837
Buffett classification: The Gruesome
Stock price: 12.7
P/E ratio: 285.8837733333333
Shares outstanding: 4051896
Book value: 88512000
P/B ratio: 0.5813796908893709
Market cap (USD): 51459079.199999996
Debt to equity: 0
Effective tax rate (%): -13.20754716981132
COGS to revenue (%): 0
SG&A to revenue (%): 65.9668905950096
Free cash flow (dilution-adjusted): 48000
Buyback yield (%): 0
Retained earnings: 52778000
Receivables turnover: 12.386329866270431
Capitalized R&D asset: 0
FCF margin (%): 0.5758157389635317
Rule of 40 score: 0.5758157389635317
Financial ratios for CLST — annual report dated 2023-12-31
Total revenue: 9044000
Net income: 526000
Capital expenditures: 172000
Operating cash flow: 2008000
Depreciation & amortization: 403000
Net tangible assets: 84559000
Owner earnings: 757000
Return on net tangible assets (%): 0.8952329142965266
Buffett classification: The Gruesome
Stock price: 10.84
P/E ratio: 83.50295178707223
Shares outstanding: 4051896
Book value: 84559000
P/B ratio: 0.5194308428434584
Market cap (USD): 43922552.64
Debt to equity: 0.11090481202474012
Effective tax rate (%): 10.391822827938672
COGS to revenue (%): 0
SG&A to revenue (%): 59.04467049977886
Free cash flow (dilution-adjusted): 1067000
Buyback yield (%): 14.377579672473242
Retained earnings: 52949000
Receivables turnover: 9.98233995584989
Capitalized R&D asset: 0
FCF margin (%): 11.797877045555063
Revenue growth (%): 8.493282149712092
Rule of 40 score: 20.291159195267156
Financial ratios for CLST — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.4
Shares outstanding: 4051896
Market cap (USD): 46191614.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLST — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.77
Shares outstanding: 4051896
Market cap (USD): 47690815.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLST — annual report dated 2024-12-31
Total revenue: 5558000
Net income: -3089000
Capital expenditures: 418000
Operating cash flow: 3172000
Depreciation & amortization: 412000
Net tangible assets: 80204000
Owner earnings: -3095000
Return on net tangible assets (%): -3.858909780060845
Buffett classification: The Gruesome
Stock price: 11.77
Shares outstanding: 4051896
Book value: 80204000
P/B ratio: 0.5946189207520822
Market cap (USD): 47690815.92
Debt to equity: 0.11917111366016657
COGS to revenue (%): 0
SG&A to revenue (%): 97.51709247930911
Free cash flow (dilution-adjusted): 1930000
Buyback yield (%): 12.07150661808178
Retained earnings: 49860000
Receivables turnover: 6.531139835487662
Capitalized R&D asset: 0
FCF margin (%): 34.72472112270601
Revenue growth (%): -38.54489164086687
Rule of 40 score: -3.8201705181608645
Financial ratios for CLST — quarterly report dated 2025-03-31
Total revenue: 2702000
Net income: 586000
Capital expenditures: 66000
Operating cash flow: 427000
Depreciation & amortization: 103000
Net tangible assets: 80591000
Owner earnings: 623000
Return on net tangible assets (%): 0.7730391731086598
Buffett classification: The Gruesome
Stock price: 11.65
P/E ratio: 20.138476279863482
Shares outstanding: 4051896
Book value: 80591000
P/B ratio: 0.5857302726110856
Market cap (USD): 47204588.4
Debt to equity: 0.11915722599297689
Effective tax rate (%): 18.61111111111111
COGS to revenue (%): 0
SG&A to revenue (%): 51.73945225758697
Free cash flow (dilution-adjusted): 160000
Buyback yield (%): 1.83456742099249
Retained earnings: 50446000
Receivables turnover: 3.120092378752887
Capitalized R&D asset: 0
FCF margin (%): 5.921539600296077
Rule of 40 score: 5.921539600296077
Financial ratios for CLST — quarterly report dated 2025-06-30
Total revenue: 2783000
Net income: 521000
Capital expenditures: 34000
Operating cash flow: 1151000
Depreciation & amortization: 105000
Net tangible assets: 80799000
Owner earnings: 592000
Return on net tangible assets (%): 0.7326823351774155
Buffett classification: The Gruesome
Stock price: 12.39
P/E ratio: 45.35048910569106
Shares outstanding: 4051896
Book value: 80799000
P/B ratio: 0.6213318412356589
Market cap (USD): 50202991.440000005
Debt to equity: 0.11939504201784676
Effective tax rate (%): 17.823343848580443
COGS to revenue (%): 0
SG&A to revenue (%): 50.26949335249731
Free cash flow (dilution-adjusted): 908000
Buyback yield (%): 1.4779995747600014
Retained earnings: 50967000
Receivables turnover: 3.1517553793884483
Capitalized R&D asset: 0
FCF margin (%): 32.62666187567373
Revenue growth (%): 2.9977794226498893
Rule of 40 score: 35.624441298323624
Financial ratios for CLST — quarterly report dated 2025-09-30
Total revenue: 2742000
Net income: 489000
Capital expenditures: 85000
Operating cash flow: 912000
Depreciation & amortization: 107000
Net tangible assets: 81585000
Owner earnings: 511000
Return on net tangible assets (%): 0.6263406263406264
Buffett classification: The Gruesome
Stock price: 13.2
P/E ratio: 33.511921804511275
Shares outstanding: 4051896
Book value: 81585000
P/B ratio: 0.655574274682846
Market cap (USD): 53485027.199999996
Debt to equity: 0.18009438009438009
Effective tax rate (%): 18.363939899833053
COGS to revenue (%): 0
SG&A to revenue (%): 53.610503282275715
Free cash flow (dilution-adjusted): 588000
Buyback yield (%): 0.3197156455779086
Retained earnings: 51456000
Receivables turnover: 3.1846689895470384
Capitalized R&D asset: 0
FCF margin (%): 21.444201312910284
Revenue growth (%): -1.4732303269852678
Rule of 40 score: 19.970970985925018
Financial ratios for CLST — annual report dated 2025-12-31
Total revenue: 11046000
Net income: 2052000
Capital expenditures: 188000
Operating cash flow: 3287000
Depreciation & amortization: 422000
Net tangible assets: 81725000
Owner earnings: 2286000
Return on net tangible assets (%): 2.7971856836953197
Buffett classification: The Gruesome
Stock price: 15.75
P/E ratio: 31.100078947368424
Shares outstanding: 4051896
Book value: 81725000
P/B ratio: 0.7808793147751607
Market cap (USD): 63817362
Debt to equity: 0.18026307739369837
Effective tax rate (%): 18.051118210862622
COGS to revenue (%): 0
SG&A to revenue (%): 52.154626108998734
Free cash flow (dilution-adjusted): 2202000
Buyback yield (%): 4.052188807177583
Retained earnings: 51912000
Receivables turnover: 12.178610804851157
Capitalized R&D asset: 0
FCF margin (%): 19.93481803367735
Revenue growth (%): 98.74055415617129
Rule of 40 score: 118.67537218984863
Financial ratios for CLST — quarterly report dated 2025-12-31
Total revenue: 2625000
Net income: 456000
Capital expenditures: 3000
Operating cash flow: 797000
Depreciation & amortization: 107000
Net tangible assets: 81725000
Owner earnings: 560000
Return on net tangible assets (%): 0.6852248394004282
Buffett classification: The Gruesome
Stock price: 15.75
P/E ratio: 31.100078947368424
Shares outstanding: 4051896
Book value: 81725000
P/B ratio: 0.7808793147751607
Market cap (USD): 63817362
Debt to equity: 0.18026307739369837
Effective tax rate (%): 17.24137931034483
COGS to revenue (%): 0
SG&A to revenue (%): 56.91428571428572
Free cash flow (dilution-adjusted): 546000
Buyback yield (%): 1.2645461590844196
Retained earnings: 51912000
Receivables turnover: 2.8941565600882027
Capitalized R&D asset: 0
FCF margin (%): 20.8
Revenue growth (%): -4.266958424507659
Rule of 40 score: 16.53304157549234
Financial ratios for CMCX.L — annual report dated 2022-03-31
Total revenue: 429793421.05263156
Gross profit: 273155263.15789473
Operating income: 133290789.4736842
Net income: 94051315.78947368
Capital expenditures: 4605263.157894737
Operating cash flow: 205369736.84210527
Depreciation & amortization: 16300000
Net tangible assets: 445460526.31578946
Owner earnings: 105746052.63157895
Return on net tangible assets (%): 23.738591050066464
Capex to operating income (%): 3.4550498020750045
Buffett classification: The Great
Stock price: 0.028289473684210524
P/E ratio: 0.08112370049944738
Shares outstanding: 269704232
Book value: 485365789.4736842
P/B ratio: 0.015719671511990413
Market cap (USD): 7629790.77368421
Debt to equity: 0.03915928843682735
Current ratio: 2.1733902220331
Quick ratio: 2.1733902220331
Effective tax rate (%): 21.876605278976992
Interest coverage ratio: 47.38119738072965
COGS to revenue (%): 36.444987340919596
R&D to revenue (%): -2.4384419687548795
SG&A to revenue (%): 11.000082659049788
Free cash flow (dilution-adjusted): 184094736.84210524
Buyback yield (%): 65.63606900093191
Retained earnings: 429265789.4736842
Receivables turnover: 2.425831031102397
Capitalized R&D asset: -10480263.157894736
ROCI (R&D-adjusted, %): 25.55391983303207
FCF margin (%): 42.833307311039874
Rule of 40 score: 42.833307311039874
Financial ratios for CMCX.L — annual report dated 2023-03-31
Total revenue: 401403703.7037037
Gross profit: 230695061.72839504
Operating income: 76879012.345679
Net income: 51159259.259259254
Capital expenditures: 8754320.98765432
Operating cash flow: 87850617.28395061
Depreciation & amortization: 19304938.271604937
Net tangible assets: 418114814.8148148
Owner earnings: 61709876.54320987
Return on net tangible assets (%): 14.759074387388424
Capex to operating income (%): 11.387140287769785
Buffett classification: The Great
Stock price: 0.01925925925925926
P/E ratio: 0.10153203550278725
Shares outstanding: 269704232
Book value: 461746913.5802468
P/B ratio: 0.011249244065612346
Market cap (USD): 5194303.727407408
Debt to equity: 0.0315976631953264
Current ratio: 2.6031637345061975
Quick ratio: 2.6031637345061975
Effective tax rate (%): 20.558633514176716
Interest coverage ratio: 26.899352051835848
COGS to revenue (%): 42.52791900029833
R&D to revenue (%): -0.05228565189443219
SG&A to revenue (%): 14.427456733623057
Free cash flow (dilution-adjusted): 50971604.938271604
Buyback yield (%): 674.2903995624893
Retained earnings: 378208641.9753086
Receivables turnover: 2.9672011462259418
Capitalized R&D asset: -7231652.85899935
ROCI (R&D-adjusted, %): 17.080422837099025
FCF margin (%): 12.698339469208364
Revenue growth (%): -6.605433205421568
Rule of 40 score: 6.092906263786795
Financial ratios for CMCX.L — annual report dated 2024-03-31
Total revenue: 455373417.721519
Gross profit: 271283544.3037975
Operating income: 104992405.06329113
Net income: 59349367.088607594
Capital expenditures: 9660759.493670886
Operating cash flow: 101373417.72151898
Depreciation & amortization: 34712658.2278481
Net tangible assets: 474160759.4936709
Owner earnings: 84401265.82278481
Return on net tangible assets (%): 17.800137217789192
Capex to operating income (%): 9.20138888888889
Buffett classification: The Great
Stock price: 0.02531645569620253
P/E ratio: 0.11504680800238877
Shares outstanding: 269704232
Book value: 510750632.9113924
P/B ratio: 0.013368471423296068
Market cap (USD): 6827955.240506329
Debt to equity: 0.041921421189463015
Current ratio: 2.1752365157486926
Quick ratio: 2.1752365157486926
Effective tax rate (%): 25.969084047810775
Interest coverage ratio: 42.513582778062535
COGS to revenue (%): 40.42613517908518
R&D to revenue (%): -0.0036136707945906127
SG&A to revenue (%): 13.765305980625165
Free cash flow (dilution-adjusted): 73565822.78481013
Buyback yield (%): 33.14742202487946
Retained earnings: 432672151.89873415
Receivables turnover: 2.7189349336034043
Capitalized R&D asset: -3615559.822258412
ROCI (R&D-adjusted, %): 20.60625650106065
FCF margin (%): 16.15505427455559
Revenue growth (%): 13.445245651657729
Rule of 40 score: 29.600299926213317
Financial ratios for CMCX.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 509158666.6666667
Buffett classification: The Gruesome
Stock price: 0.03906666666666667
Shares outstanding: 269704232
Book value: 547976000
P/B ratio: 0.01922793211770832
Market cap (USD): 10536445.330133336
Debt to equity: 0.03490177185375515
Current ratio: 1.989183204902757
Quick ratio: 1.989183204902757
Buyback yield (%): 0
Retained earnings: 479154666.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMCX.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 505097402.5974026
Buffett classification: The Gruesome
Stock price: 0.025454545454545452
Shares outstanding: 269704232
Book value: 542814285.7142856
P/B ratio: 0.012647417014261891
Market cap (USD): 6865198.632727272
Debt to equity: 0.03431371376209127
Current ratio: 2.139815123806981
Quick ratio: 2.139815123806981
Buyback yield (%): 0
Retained earnings: 490233766.2337662
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMCX.L — annual report dated 2025-03-31
Total revenue: 467661038.96103895
Gross profit: 294057142.85714287
Operating income: 122611688.3116883
Net income: 80762337.66233766
Capital expenditures: 3932467.5324675324
Operating cash flow: 227728571.42857143
Depreciation & amortization: 18198701.298701297
Net tangible assets: 505097402.5974026
Owner earnings: 95028571.42857143
Return on net tangible assets (%): 18.813910136915858
Capex to operating income (%): 3.2072533920835498
Buffett classification: The Great
Stock price: 0.025454545454545452
P/E ratio: 0.08500495195458858
Shares outstanding: 269704232
Book value: 542814285.7142856
P/B ratio: 0.012647417014261891
Market cap (USD): 6865198.632727272
Debt to equity: 0.03431371376209127
Current ratio: 2.139815123806981
Quick ratio: 2.139815123806981
Effective tax rate (%): 26.36583228739906
Interest coverage ratio: 49.58560924369748
COGS to revenue (%): 37.12173596705351
R&D to revenue (%): 0
SG&A to revenue (%): 12.927278331792092
Free cash flow (dilution-adjusted): 211255844.15584415
Buyback yield (%): 283.77646771858696
Retained earnings: 490233766.2337662
Receivables turnover: 3.0667603474706184
Capitalized R&D asset: -80284.57571495546
ROCI (R&D-adjusted, %): 21.854885163202876
FCF margin (%): 45.17285524258607
Revenue growth (%): 2.698361555885631
Rule of 40 score: 47.8712167984717
Financial ratios for CMCX.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 530695945.945946
Buffett classification: The Gruesome
Stock price: 0.03175675675675676
Shares outstanding: 269704232
Book value: 575048648.6486487
P/B ratio: 0.014894273227177016
Market cap (USD): 8564931.691891892
Debt to equity: 0.046628252368777254
Current ratio: 2.121085706226199
Quick ratio: 2.121085706226199
Buyback yield (%): 0
Retained earnings: 526193243.2432433
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DESN.SW — annual report dated 2022-03-31
Total revenue: 273840217.3913043
Gross profit: 215883695.6521739
Operating income: 74504347.82608695
Net income: 64444565.217391305
Capital expenditures: 85930434.78260869
Operating cash flow: 39363043.47826087
Depreciation & amortization: 22960869.56521739
Net tangible assets: 776913043.4782609
Owner earnings: 1475000
Return on net tangible assets (%): 0.18985393698584138
Capex to operating income (%): 115.3361344537815
Buffett classification: The Gruesome
Stock price: 276.0869565217391
P/E ratio: 59.22539793216279
Shares outstanding: 13824467
Book value: 777145652.173913
P/B ratio: 4.911247986640073
Market cap (USD): 3816755019.5652175
Debt to equity: 0
Current ratio: 4.01075936271467
Quick ratio: 2.6665067810319205
Effective tax rate (%): 14.96005393077927
Interest coverage ratio: 175.30434782608694
COGS to revenue (%): 21.164357190205333
SG&A to revenue (%): 1.7330004405933326
Free cash flow (dilution-adjusted): -46598913.04347826
Buyback yield (%): 0
Retained earnings: 494601086.9565217
Inventory turnover: 0.3730523546656032
Receivables turnover: 3.6351345501767542
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.113863459582362
FCF margin (%): -17.016825902124772
Rule of 40 score: -17.016825902124772
Financial ratios for DESN.SW — annual report dated 2023-03-31
Total revenue: 351046153.84615386
Gross profit: 250642857.14285713
Operating income: 105856043.95604396
Net income: 96389010.98901099
Capital expenditures: 149657142.85714287
Operating cash flow: 98387912.08791208
Depreciation & amortization: 22606593.406593405
Net tangible assets: 882112087.9120879
Owner earnings: -30661538.461538464
Return on net tangible assets (%): -3.47592317140928
Capex to operating income (%): 141.3779858609557
Buffett classification: The Gruesome
Stock price: 285.7142857142857
P/E ratio: 40.97819527099437
Shares outstanding: 13824467
Book value: 882382417.5824176
P/B ratio: 4.476344536768589
Market cap (USD): 3949847714.2857146
Debt to equity: 0.07472277849179543
Current ratio: 3.0316357319191733
Quick ratio: 1.9403401298345067
Effective tax rate (%): 6.900175131348512
Interest coverage ratio: 45.459650778669186
COGS to revenue (%): 28.601166998484906
SG&A to revenue (%): 1.6011795199278767
Free cash flow (dilution-adjusted): -51484615.384615384
Buyback yield (%): 0
Retained earnings: 595828571.4285715
Inventory turnover: 0.5467901877352676
Receivables turnover: 4.530848438430772
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.691592145876875
FCF margin (%): -14.666053115961084
Revenue growth (%): 28.193790229331444
Rule of 40 score: 13.52773711337036
Financial ratios for DESN.SW — annual report dated 2024-03-31
Total revenue: 362522222.2222222
Gross profit: 241263333.3333333
Operating income: 100156666.66666667
Net income: 89584444.44444445
Capital expenditures: 176638888.8888889
Operating cash flow: 114081111.1111111
Depreciation & amortization: 22931111.111111112
Net tangible assets: 982067777.7777778
Owner earnings: -64123333.33333334
Return on net tangible assets (%): -6.5294203500324155
Capex to operating income (%): 176.36258750180275
Buffett classification: The Gruesome
Stock price: 261.53846153846155
P/E ratio: 40.36001845176876
Shares outstanding: 13824467
Book value: 984174444.4444444
P/B ratio: 3.6737692704571434
Market cap (USD): 3615629830.769231
Debt to equity: 0.11289778121990568
Current ratio: 2.5575051823664476
Quick ratio: 1.5723329163950692
Effective tax rate (%): 12.809421332093304
Interest coverage ratio: 95.58960763520679
COGS to revenue (%): 33.4486774757103
SG&A to revenue (%): 1.7963649737947098
Free cash flow (dilution-adjusted): -63820000
Buyback yield (%): 0
Retained earnings: 693418888.8888888
Inventory turnover: 0.6505150091795617
Receivables turnover: 6.012531097392427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.821336162183956
FCF margin (%): -17.60443804211236
Revenue growth (%): 3.2691052872488515
Rule of 40 score: -14.335332754863508
Financial ratios for DESN.SW — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1090150000
Buffett classification: The Gruesome
Stock price: 308.33333333333337
Shares outstanding: 13824467
Book value: 1092779761.904762
P/B ratio: 3.900643240534461
Market cap (USD): 4262543991.666667
Debt to equity: 0
Current ratio: 2.376824205693109
Quick ratio: 1.3658853700111078
Buyback yield (%): 0
Retained earnings: 780195238.0952381
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DESN.SW — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1124776136.3636363
Buffett classification: The Gruesome
Stock price: 210.45454545454544
Shares outstanding: 13824467
Book value: 1127337500
P/B ratio: 2.5807905074002804
Market cap (USD): 2909421918.6363635
Debt to equity: 0.13104085753137168
Current ratio: 2.674468570458512
Quick ratio: 1.6455085118911836
Buyback yield (%): 0
Retained earnings: 828961363.6363636
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DESN.SW — annual report dated 2025-03-31
Total revenue: 437762500
Gross profit: 294875000
Operating income: 135598863.63636363
Net income: 119975000
Capital expenditures: 143498863.63636363
Operating cash flow: 108712500
Depreciation & amortization: 25043181.818181816
Net tangible assets: 1124776136.3636363
Owner earnings: 1519318.1818181872
Return on net tangible assets (%): 0.13507738408552053
Capex to operating income (%): 105.82600752553905
Buffett classification: The Gruesome
Stock price: 210.45454545454544
P/E ratio: 24.250234787550433
Shares outstanding: 13824467
Book value: 1127337500
P/B ratio: 2.5807905074002804
Market cap (USD): 2909421918.6363635
Debt to equity: 0.13104085753137168
Current ratio: 2.674468570458512
Quick ratio: 1.6455085118911836
Effective tax rate (%): 13.088074285667242
Interest coverage ratio: 97.88925348646431
COGS to revenue (%): 32.64041575054967
SG&A to revenue (%): 1.5974830686003982
Free cash flow (dilution-adjusted): -35679545.45454545
Buyback yield (%): 0
Retained earnings: 828961363.6363636
Inventory turnover: 0.6482831511651888
Receivables turnover: 3.714215468867506
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.271686172428872
FCF margin (%): -8.15043441467587
Revenue growth (%): 20.754666380605023
Rule of 40 score: 12.604231965929154
Financial ratios for DESN.SW — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 1296846250
Buffett classification: The Gruesome
Stock price: 376.25
Shares outstanding: 13824467
Book value: 1300051250
P/B ratio: 4.000962045727043
Market cap (USD): 5201455708.75
Debt to equity: 0
Current ratio: 2.9433952708406017
Quick ratio: 1.705153455707742
Buyback yield (%): 0
Retained earnings: 970667500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNL.AX — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.5251798561151082
Shares outstanding: 1752800601
Market cap (USD): 2673336168.4316554
Buyback yield (%): 0.026911110878124752
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNL.AX — annual report dated 2022-09-30
Total revenue: 4100844155.844156
Gross profit: 2167012987.012987
Operating income: 830779220.7792208
Net income: 658311688.3116883
Capital expenditures: 278116883.1168831
Depreciation & amortization: 241883116.88311687
Net tangible assets: 1953376623.3766234
Owner earnings: 622077922.0779221
Return on net tangible assets (%): 31.84628681603617
Capex to operating income (%): 33.476629670157884
Buffett classification: The Good
Stock price: 1.7337662337662336
P/E ratio: 4.616273036762674
Shares outstanding: 1752800601
Book value: 4084220779.220779
P/B ratio: 0.7440700835763231
Market cap (USD): 3038946496.538961
Debt to equity: 0.31128670683816395
Current ratio: 1.45417191694516
Quick ratio: 0.9098230427874872
Effective tax rate (%): 25.39005004415661
Interest coverage ratio: 12.361352657004831
COGS to revenue (%): 47.15690466011116
SG&A to revenue (%): 17.99439456557883
Free cash flow (dilution-adjusted): 428116883.1168831
Buyback yield (%): 0
Retained earnings: 1585519480.5194805
Inventory turnover: 2.9972826086956523
Receivables turnover: 8.346946867565425
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.155160205346078
FCF margin (%): 10.439725745411936
Rule of 40 score: 10.439725745411936
Financial ratios for DNL.AX — annual report dated 2023-09-30
Total revenue: 3468525641.025641
Gross profit: 1590961538.4615383
Operating income: 228974358.97435898
Net income: 358974358.974359
Capital expenditures: 308846153.84615386
Depreciation & amortization: 208141025.64102563
Net tangible assets: 2584871794.8717947
Owner earnings: 258269230.76923072
Return on net tangible assets (%): 9.99156829679595
Capex to operating income (%): 134.88241881298993
Buffett classification: The Gruesome
Stock price: 1.6602564102564101
P/E ratio: 8.106702779625
Shares outstanding: 1752800601
Book value: 4119679487.1794877
P/B ratio: 0.7063895244199977
Market cap (USD): 2910098433.7115383
Debt to equity: 0.30597351673487166
Current ratio: 3.2531742389475298
Quick ratio: 2.627963897812452
Effective tax rate (%): 12.885948330182734
Interest coverage ratio: 2.376580172987359
COGS to revenue (%): 54.131475355301326
SG&A to revenue (%): 23.19577149827201
Free cash flow (dilution-adjusted): 131858974.35897435
Buyback yield (%): 0
Retained earnings: 1587115384.6153846
Inventory turnover: 3.5833129434793243
Receivables turnover: 9.49114190492896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.866679656631919
FCF margin (%): 3.8015856881479975
Revenue growth (%): -15.419228109836633
Rule of 40 score: -11.617642421688636